<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04396119</url>
  </required_header>
  <id_info>
    <org_study_id>CFTSp178</org_study_id>
    <secondary_id>276443</secondary_id>
    <nct_id>NCT04396119</nct_id>
  </id_info>
  <brief_title>Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study</brief_title>
  <official_title>Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Christie NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Christie NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore the topic of lung cancer screening following treatment for Hodgkin lymphoma from&#xD;
      the perspective of survivors&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Explore survivors' attitudes towards lung cancer and lung cancer screening Explore survivors'&#xD;
      understanding of cancer screening as a concept and the benefits of screening and early&#xD;
      detection Explore survivors' level of awareness of and attitudes towards their lung cancer&#xD;
      risk Explore survivors' views on the barriers and motivating factors that would impact their&#xD;
      decision to attend a lung cancer screening test&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 11, 2020</start_date>
  <completion_date type="Actual">April 13, 2020</completion_date>
  <primary_completion_date type="Actual">April 13, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Explore survivors' attitudes towards lung cancer and lung cancer screening</measure>
    <time_frame>6 months</time_frame>
    <description>Semi-structured interviews</description>
  </primary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Hodgkin Lymphoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Participants who have previously been treated for Hodgkin lymphoma without evidence of&#xD;
        relapse for at least 5 years&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Details held in the ADAPT database at The Christie NHS Foundation trust&#xD;
&#xD;
          -  Responded to most recent ADAPT study questionnaire (April - August 2019)&#xD;
&#xD;
          -  Aged 18-80&#xD;
&#xD;
          -  Previously treated for Hodgkin lymphoma without evidence of relapse for at least 5&#xD;
             years&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
          -  Treated with radiotherapy (with lung tissue in the radiotherapy field) and/or&#xD;
             alkylating agent containing chemotherapy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous or current diagnosis of lung cancer&#xD;
&#xD;
          -  Stated within 2019 health questionnaire that they did not wish to be contacted&#xD;
&#xD;
          -  Have participated in lung cancer screening through the Manchester Lung Health Checks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Christie NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <zip>M20 4BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>January 31, 2020</study_first_submitted>
  <study_first_submitted_qc>May 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2020</study_first_posted>
  <last_update_submitted>September 2, 2020</last_update_submitted>
  <last_update_submitted_qc>September 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Hodgkin Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>It is not intended to share IPD with other researchers outside the study team</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

